BR0307199A - Derivados de drechsleranol, processo para a sua preparação e sua aplicação - Google Patents

Derivados de drechsleranol, processo para a sua preparação e sua aplicação

Info

Publication number
BR0307199A
BR0307199A BR0307199-5A BR0307199A BR0307199A BR 0307199 A BR0307199 A BR 0307199A BR 0307199 A BR0307199 A BR 0307199A BR 0307199 A BR0307199 A BR 0307199A
Authority
BR
Brazil
Prior art keywords
preparation
application
drechsleranol
derivatives
disorders
Prior art date
Application number
BR0307199-5A
Other languages
English (en)
Inventor
Claudia Eder
Michael Kurz
Luigi Toti
Original Assignee
Aventis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Gmbh filed Critical Aventis Pharma Gmbh
Publication of BR0307199A publication Critical patent/BR0307199A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/04—Chelating agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/14—Fungi; Culture media therefor
    • C12N1/145—Fungal isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/02—Oxygen as only ring hetero atoms
    • C12P17/04—Oxygen as only ring hetero atoms containing a five-membered hetero ring, e.g. griseofulvin, vitamin C
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/645—Fungi ; Processes using fungi

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Psychiatry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Hospice & Palliative Care (AREA)
  • Anesthesiology (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Pain & Pain Management (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Furan Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

"DERIVADOS DE DRECHSLERANOL, PROCESSO PARA A SUA PREPARAçãO E SUA APLICAçãO". A presente invenção refere-se a modernos compostos da fórmula (I) mencionados drechsleranóis, que são formados durante a fermentação pelos microorganismos Drechslera australiensis, ST 003360, DSM 14093 ou ST 004112, DSM 14524, um processo para a sua preparação, a aplicação de drechsieranóis como medicamento, especialmente para o tratamento e/ou profilaxia de neuropatias degenerativas, por exemplo, da doença de Alzheimer, ou doenças psíquicas, tais como depressão, distúrbios do sono ou distúrbios afetivos condicionados sazonalmente e o emprego de drechsleranóis como formadores de quelato ou antioxidantes.
BR0307199-5A 2002-01-29 2003-01-20 Derivados de drechsleranol, processo para a sua preparação e sua aplicação BR0307199A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10203557A DE10203557A1 (de) 2002-01-29 2002-01-29 Drechsleranol-Derivate, Verfahren zu deren Herstellung und deren Verwendung
PCT/EP2003/000487 WO2003064405A1 (de) 2002-01-29 2003-01-20 Drechsleranol-derivate, verfahren zu deren herstellung und deren verwendung

Publications (1)

Publication Number Publication Date
BR0307199A true BR0307199A (pt) 2004-11-03

Family

ID=7713383

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0307199-5A BR0307199A (pt) 2002-01-29 2003-01-20 Derivados de drechsleranol, processo para a sua preparação e sua aplicação

Country Status (12)

Country Link
EP (1) EP1472240B1 (pt)
JP (1) JP4436134B2 (pt)
AR (1) AR038233A1 (pt)
AT (1) ATE466848T1 (pt)
AU (1) AU2003201963B2 (pt)
BR (1) BR0307199A (pt)
CA (1) CA2473988C (pt)
DE (2) DE10203557A1 (pt)
IL (1) IL163166A (pt)
MX (1) MXPA04006358A (pt)
PE (1) PE20030815A1 (pt)
WO (1) WO2003064405A1 (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105339362B (zh) * 2013-06-26 2017-09-01 Dic株式会社 含酚性羟基化合物、酚醛树脂、固化性组合物、其固化物、半导体密封材料、及印刷电路基板

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3068706B2 (ja) * 1992-02-26 2000-07-24 塩野義製薬株式会社 アルド−ス還元酵素阻害物質

Also Published As

Publication number Publication date
JP4436134B2 (ja) 2010-03-24
CA2473988A1 (en) 2003-08-07
CA2473988C (en) 2011-05-03
EP1472240A1 (de) 2004-11-03
PE20030815A1 (es) 2003-10-10
WO2003064405A1 (de) 2003-08-07
IL163166A (en) 2008-08-07
ATE466848T1 (de) 2010-05-15
AU2003201963B2 (en) 2008-06-05
EP1472240B1 (de) 2010-05-05
JP2006503797A (ja) 2006-02-02
AR038233A1 (es) 2005-01-05
DE10203557A1 (de) 2003-08-07
MXPA04006358A (es) 2004-10-04
DE50312692D1 (de) 2010-06-17

Similar Documents

Publication Publication Date Title
BR0312729A (pt) Novos derivados de indol-3-enxofre
MY139552A (en) Phenethanolamine derivatives for treatment of respiratory diseases
MXPA04002405A (es) Derivados de fenetanolamina para tratamiento de enfermedades respiratorias.
BR0010555A (pt) Inibidores de neuraminidases
MXPA03010232A (es) Compuestos de arilsulfonamida, para el tratamiento de la obesidad, de la diabetes tipo ii y de trastornos del sistema nervioso central.
BRPI0609784B8 (pt) compostos éster de n-alquilcarbonil-aminoácido e n-alquilcarbonil-amino lactona, composição, e, uso de um composto
IL196391A0 (en) Pyrrolopyrimidines for pharmaceutical compositions
BR0215182A (pt) Derivados de (alfa)- (n-sulfonamido) acetamida como inibidores de (beta)-amilóide
IL175762A0 (en) Use of substituted 2-aminotetralines for the preventative treatment of parkinson's disease
BR0209127A (pt) compostos, composições farmacêuticas, métodos para o tratamento de dores, métodos para a modulação de uma resposta farmacológica e usos de compostos
TW200736213A (en) Dicarboxylic acid derivatives and their use
BR0209129A (pt) Compostos, composições farmacêuticas, métodos para tratamento de dores, métodos para modulação de uma resposta farmacológica e usos de compostos
BR0312232A (pt) Inibidores de caspases e seus usos
BR0314611A (pt) Compostos de tiazol para o tratamento de distúrbios neurodegenerativos
BR0315158A (pt) Compostos de pirazol para o tratamento de distúrbios neurodegenarativos
SG151336A1 (en) 1,3,4-oxadiazol-2-ones as ppar delta
BR0314299A (pt) Derivados de pirrolidona como inibidores de mao-b
IL178167A0 (en) 1,3,4-oxadiazol-2-ones as ppar delta modulators
BR0316723A (pt) Derivados de anilinopirazol úteis para o tratamento de diabetes
BRPI0408882A (pt) composições contendo lactulose para tratamento de infecções por rotavìrus
BR0209128A (pt) Compostos, composições farmacêuticas, métodos para o tratamento de dores, métodos para a modulação de uma resposta farmacológica e usos de compostos
MX2022012575A (es) Compuestos para usarse para tratar la enfermedad de huntington.
SE9903894D0 (sv) Novel compounds
BRPI0801239A2 (pt) uso de um ou mais benzopiranonas, composição farmacêutica e método de prevenção ou tratamento de doenças, disfunções e distúrbios associados a monoamino oxidase
BR0306855A (pt) Método para o tratamento de distúrbios cognitivos

Legal Events

Date Code Title Description
B25D Requested change of name of applicant approved

Owner name: SANOFI-AVENTIS DEUTSCHLAND GMBH (DE)

Free format text: ALTERADO DE: AVENTIS PHARMA DEUTSCHLAND GMBH

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B15K Others concerning applications: alteration of classification

Free format text: ALTERADA DA INT.CL: C07D 307/77, C12P 17/04, C12 1/14, A61K 31/34, A61P 25/00

Ipc: C07D 307/79 (2006.01), C12P 17/04 (2006.01), C12N

B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B11B Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements